Remove Capital Remove Develop Remove Invest Remove Seed Funding
article thumbnail

Blacksmith Medicines Gets Seed Funding

socalTECH

San Diego-based Blacksmith Medicines, a new biotechnology company focused on creating medicines for immuno-oncology and inflammatory diseases by targeting human metalloenzymes, has raised a round of seed funding, and announced a research deal with Lilly. Financial details of that seed funding were not announced.

article thumbnail

Moonshots Capital Leads Investment In Backtracks

socalTECH

Los Angeles-based venture investor Moonshots Capital is the lead investor in a new startup, Backtracks , a developer of podcast analytics software. in a seed funding round, which was led by Moonshots Capital, and also included Capital Factory, Sputnik ATX, Next Coast Ventures, Bull Creek Capital, and BNSG Capital.

Capital 133
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Moonshots Capital Leads Investment In Complai, Developer Of Shep

socalTECH

Los Angeles- and Austin-based Moonshots Capital , the new venture investment fund founded by Kelly Perdew and Craig Cummings, is on an investment roll, and has made another investment from its fund.

Capital 113
article thumbnail

Moonshots Capital Ramps Investment Pace With Lead On Two Investments

socalTECH

Los Angeles- and Austin-based Moonshots Capital , the venture capital fund led by serial entrepreneur Kelly Perdew, is ramping its investment pace, with the first two formal investments out of its new fund. seed funding in that firm. Moonshots also led the investment in New Knowledge.

Invest 150
article thumbnail

SeqOnce Biosciences Finds $1M In Seed Funding

socalTECH

Pasadena-based SeqOnce Biosciences , which is developing next generation sequencing technology, has raised $1M in a seed funding round, according to the company. According to SeqOnce, it will use the new funding for commercialization of a library construction kit for whole genome next generation sequencing (NGS).

article thumbnail

Why Has Seed Investing Declined? And What Does this Mean for the Future?

Both Sides of the Table

Seed investments are down by any measure (funds, deals, dollars) over the past 3 years in deals < $1 million AND in deals between $1–5 million. As a result of the IPO window shifting we saw a massive inflow of public-market capital into the latest stages of venture. thus the rise of “pre seedinvesting).

article thumbnail

MEDU takes in $4M to develop reusable personal protective equipment

TechCrunch LA

The company started trials in Mexican hospitals, buoyed by an initial $400,000 investment, to test and certify the results and see if doctors liked wearing the products. The funding gives the company fuel to grow as it expands into the U.S. and continues development of its full-body suit. by the end of the year.

Develop 257